Utku Goreke

TL;DR: The results suggest that the microfluidic BioChip system is a promising in vitro assay with which to screen patients, monitor treatment response, and guide current and emerging anti-adhesive therapies in SCD.

TL;DR: It is concluded that radiotherapy exposure may alter the deformability of red blood cells depending on the dose amount, and measurement of deformability index by dual-beam optical tweezers can serve as a sensitive biomarker to probe responses of cells to the radiotherapy.

TL;DR: In this paper, a point-of-care (POC) platform was proposed to perform both anemia detection and Hb variant identification using a single paper-based electrophoresis test.

TL;DR: In this article, a review of point-of-care (POC) screening, early diagnosis, and monitoring of anemia is presented, highlighting the future trends of integrating anemia detection with the diagnosis of relevant underlying disorders to accurately identify specific root causes and to facilitate personalized treatment and care.

TL;DR: A microfluidic, magnetic levitation-based assay that detects minute density differences of individual red blood cells (RBCs) down to 0.0001 g mL-1 resolution that enables rapid, accurate, density-based imaging, profiling and label-free monitoring of single RBCs and introduced a new term as a measure of density dispersion, RBC levitational density width, RLDW.